Table 4 Status of PC education and research in Chinese hospitals participating in the study
Tertiary general hospitals (n = 268) | Cancer hospitals (n = 99) | p value | |||
|---|---|---|---|---|---|
n | % (95%CI) | n | % (95%CI) | ||
PC training program available | 0.014 | ||||
Yes | 24 | 9.0 (5.5–12.4) | 18 | 18.2 (10.6–25.8) | |
No | 244 | 91.0 (87.6–94.5) | 81 | 81.8 (74.2–89.4) | |
Professional requirement | |||||
PC board certification for physicians | 41/226 | 18.1 (13.1–23.2) | 16/82 | 19.5 (10.9–28.1) | 0.784 |
PC board certification for nurses | 36/226 | 15.9 (11.2–20.7) | 18/82 | 22.0 (13.0–30.9) | 0.219 |
Use of patient-reported outcomes in hospitals offering PC | 90/226 | 39.8(33.4–46.2) | 37/82 | 45.1 (34.4–55.9) | 0.404 |
PROM-NRS pain scale | 75/226 | 33.2 (27.0–39.3) | 32/82 | 39.0 (28.5–49.6) | 0.342 |
PROM-multidimensional scale (BPI) | 57/226 | 25.2 (19.6–30.9) | 25/82 | 30.5 (28.5–49.6) | 0.355 |
PROM-multi symptom assessment (MDASI) | 37/226 | 16.4 (11.5–21.2) | 13/82 | 15.9 (7.9–23.8) | 0.913 |
PC scale (ESAS) | 25/226 | 11.1 (7.0–15.2) | 10/82 | 12.2 (5.1–19.3) | 0.782 |
PC topics offered at grand rounds | 0.095 | ||||
Yes | 66 | 24.6 (19.5–29.8) | 33 | 33.3 (24.0–42.6) | |
No | 202 | 75.4 (70.2–80.5) | 66 | 66.7 (57.4–76.0) | |
Hospitals offering PC grand rounds | 66 | 33 | 0.999 | ||
PC grand rounds offered to oncologists | 65 | 98.5 (95.5–101.4) | 32 | 97.0 (91.1–102.8) | |
PC research projects available | < 0.001 | ||||
Yes | 25 | 9.3 (5.8–12.8) | 17 | 17.2 (9.7–24.6) | |
No | 243 | 90.7 (87.2–94.2) | 82 | 82.8 (75.4–90.3) | |
Among hospitals with research projects available | 25 | 17 | |||
Receives research funding | 0.913 | ||||
Yes | 5 | 20.0 (4.3–35.7) | 4 | 23.5 (3.4–43.7) | |
No | 20 | 80.0 (64.3–95.7) | 13 | 76.5 (56.3–96.6) | |
PC research conducted in the past year | |||||
Prospective therapeutic RCT | 3 | 12.0 (− 0.7–24.7) | 5 | 29.4 (7.8–51.1) | 0.312 |
Prospective non-therapeutic study | 3 | 12.0 (− 0.7–24.7) | 1 | 5.9 (− 5.3–17.1) | 0.899 |
Other prospective study | 3 | 12.0 (− 0.7–24.7) | 7 | 41.2 (17.8–64.6) | 0.070 |
Retrospective study | 14 | 56.0 (36.5–75.5) | 7 | 41.2 (17.8–64.6) | 0.346 |
Case report | 15 | 60.0 (40.8–79.2) | 12 | 70.6 (48.9–92.2) | 0.482 |
Qualitative study | 3 | 12.0 (− 0.7–24.7) | 2 | 11.8 (− 3.6–27.1) | 0.634 |
Other | 1 | 4.0 (− 3.7–11.7) | 0 | 0 | 0.999 |
None | 2 | 8.0 (− 2.6–18.6) | 1 | 5.9 (− 5.3–17.1) | 0.727 |